Submitted by web@researchtop... on Fri, 07/23/2010 - 09:16
Safety and Efficacy of Bosutinib in Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After Resistance or Intolerance to Imatinib
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from July 27, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from a recent interview with Hagop M Kantarjian, MD (6/30/10)
Cortes JE et al. Safety and efficacy of bosutinib (SKI-606) in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) following resistance or intolerance to imatinib (IM). Proc ASCO 2010;Abstract 6502.